DYCLONINE HYDROCHLORIDE

DYCLONINE HYDROCHLORIDE was reported 95 times

DYCLONINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SOFT TISSUE SWELLING 16 0.0282
1 SOFT TISSUE DISORDER 23 0.0207
2 LYMPHADENITIS 29 0.0120
3 CD19 LYMPHOCYTES DECREASED 1 0.0077
4 PNEUMONIA VIRAL 24 0.0075
5 HEART RATE ABNORMAL 40 0.0072
6 BURNOUT SYNDROME 3 0.0053
7 BLOOD MAGNESIUM DECREASED 40 0.0046
8 LYMPH NODE PAIN 6 0.0032
9 ARTHRITIS ENTEROPATHIC 1 0.0031
10 C-REACTIVE PROTEIN ABNORMAL 17 0.0026
11 SEXUAL ABUSE 1 0.0023
12 MENTAL FATIGUE 3 0.0020
13 CLOSTRIDIUM DIFFICILE INFECTION 40 0.0018
14 TENDERNESS 19 0.0018
15 MUSCLE TWITCHING 40 0.0017
16 SYNOVITIS 29 0.0016
17 DYSBIOSIS 1 0.0012
18 FIBROMYALGIA 27 0.0011
19 ORAL PAIN 22 0.0010
20 LIVER FUNCTION TEST ABNORMAL 27 0.0009
21 PRODUCTIVE COUGH 44 0.0009
22 CHRONIC GASTRITIS 2 0.0009
23 LYMPHADENOPATHY 29 0.0008
24 BLOOD PRESSURE DIASTOLIC ABNORMAL 2 0.0008
25 DUODENAL ULCER HAEMORRHAGE 2 0.0007
26 LOSS OF EMPLOYMENT 2 0.0007
27 INTESTINAL POLYP 1 0.0006
28 FEBRILE NEUTROPENIA 40 0.0006
29 BLOOD CHOLESTEROL INCREASED 27 0.0006
30 SERUM FERRITIN DECREASED 1 0.0006
31 MUSCLE SPASTICITY 7 0.0006
32 LEUKOPENIA 28 0.0006
33 HYPOPROTEINAEMIA 1 0.0005
34 SKIN ATROPHY 3 0.0005
35 THROMBOSIS 40 0.0005
36 INFECTION 70 0.0005
37 HERPES ZOSTER 27 0.0005
38 C-REACTIVE PROTEIN INCREASED 17 0.0005
39 EAR PAIN 9 0.0005
40 BODY TEMPERATURE INCREASED 9 0.0004
41 EAR DISORDER 2 0.0004
42 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
43 WHITE BLOOD CELL COUNT DECREASED 45 0.0004
44 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
45 CEREBRAL DISORDER 3 0.0004
46 PLATELET COUNT DECREASED 43 0.0004
47 ARTHRITIS 30 0.0004
48 MUSCLE DISORDER 3 0.0004
49 EOSINOPHILIC OESOPHAGITIS 1 0.0004
50 OESOPHAGEAL STENOSIS 1 0.0004
51 BRAIN NEOPLASM 3 0.0003
52 NEOPLASM PROGRESSION 11 0.0003
53 STOMATITIS 19 0.0003
54 WALKING AID USER 2 0.0003
55 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 21 0.0003
56 REGURGITATION 1 0.0003
57 NERVE INJURY 3 0.0003
58 SWELLING 23 0.0002
59 JOINT SWELLING 29 0.0002
60 DISEASE PROGRESSION 28 0.0002
61 RESPIRATORY DISORDER 7 0.0002
62 NIGHT SWEATS 7 0.0002
63 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
64 HYPOTENSION 40 0.0002
65 DRUG INTOLERANCE 19 0.0002
66 PERIPHERAL SWELLING 30 0.0002
67 POOR VENOUS ACCESS 2 0.0002
68 IRRITABLE BOWEL SYNDROME 4 0.0002
69 PERICARDITIS 3 0.0002
70 ACCIDENT 2 0.0002
71 HYPERLIPIDAEMIA 2 0.0002
72 RHEUMATOID ARTHRITIS 19 0.0002
73 ARTHRALGIA 65 0.0002
74 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
75 SINUS CONGESTION 2 0.0001
76 ANAEMIA 28 0.0001
77 MASS 2 0.0001
78 HYPOALBUMINAEMIA 1 0.0001
79 GINGIVAL PAIN 1 0.0001
80 WEIGHT DECREASED 29 0.0001
81 HYPERCHOLESTEROLAEMIA 1 0.0001
82 URINARY INCONTINENCE 3 0.0001
83 DISABILITY 2 0.0001
84 HEAD INJURY 3 0.0001
85 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
86 SKIN DISORDER 3 0.0001
87 SNEEZING 2 0.0001
88 BONE PAIN 5 0.0001
89 PRODUCT USE ISSUE 16 0.0001
90 PRODUCT TASTE ABNORMAL 1 0.0001
91 BLOOD TEST ABNORMAL 1 0.0001
92 SINUSITIS 7 0.0001
93 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
94 URTICARIA 11 0.0001
95 SKIN DISCOLOURATION 3 0.0001
96 SCIATICA 1 0.0001
97 HYPOTHYROIDISM 2 0.0001
98 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
99 GASTRIC DISORDER 2 0.0001
100 MUSCULOSKELETAL PAIN 3 0.0001
101 LYMPHOCYTE COUNT DECREASED 1 0.0001
102 THIRST 1 0.0001
103 ADVERSE DRUG REACTION 5 0.0001
104 MYELOSUPPRESSION 2 0.0001
105 FLATULENCE 3 0.0001
106 HAEMORRHOIDS 1 0.0001
107 FULL BLOOD COUNT DECREASED 1 0.0000
108 NEUTROPHIL COUNT DECREASED 2 0.0000
109 ASTHENIA 18 0.0000
110 MOUTH ULCERATION 1 0.0000
111 CONDITION AGGRAVATED 14 0.0000
112 BURNING SENSATION 3 0.0000
113 MOBILITY DECREASED 3 0.0000
114 INTERSTITIAL LUNG DISEASE 2 0.0000
115 UNDERDOSE 3 0.0000
116 JOINT STIFFNESS 1 0.0000
117 INTENTIONAL PRODUCT MISUSE 3 0.0000
118 ABDOMINAL PAIN UPPER 7 0.0000
119 INSOMNIA 9 0.0000
120 IRRITABILITY 2 0.0000
121 ILL-DEFINED DISORDER 2 0.0000
122 HYPERSENSITIVITY 6 0.0000
123 RHINORRHOEA 2 0.0000
124 INFUSION RELATED REACTION 2 0.0000
125 BACK PAIN 7 0.0000
126 RASH 13 0.0000
127 MALAISE 13 0.0000
128 PYREXIA 10 0.0000
129 PRURITUS 11 0.0000
130 FATIGUE 21 0.0000
131 DYSGEUSIA 2 0.0000
132 HOT FLUSH 2 0.0000
133 MUSCULAR WEAKNESS 3 0.0000
134 COLITIS 1 0.0000
135 ACNE 2 0.0000
136 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
137 CHILLS 3 0.0000
138 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
139 EMOTIONAL DISTRESS 3 0.0000
140 PSORIATIC ARTHROPATHY 1 0.0000
141 ABDOMINAL DISCOMFORT 4 0.0000
142 LOSS OF CONSCIOUSNESS 3 0.0000
143 HYPERHIDROSIS 3 0.0000
144 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
145 HYPOKALAEMIA 1 0.0000
146 NAUSEA 17 0.0000
147 VOMITING 10 0.0000
148 PAIN 13 0.0000
149 OCULAR HYPERAEMIA 1 0.0000
150 MIGRAINE 2 0.0000
151 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
152 ILLNESS 2 0.0000
153 PARAESTHESIA 3 0.0000
154 OFF LABEL USE 16 0.0000
155 DRUG INEFFECTIVE 24 0.0000
156 ANXIETY 5 0.0000
157 COVID-19 3 0.0000
158 NASOPHARYNGITIS 3 0.0000
159 HEADACHE 10 0.0000
160 FEELING ABNORMAL 3 0.0000
161 DIARRHOEA 8 0.0000
162 TREATMENT FAILURE 1 0.0000
163 SKIN EXFOLIATION 1 0.0000
164 MUSCULOSKELETAL STIFFNESS 1 0.0000
165 ADVERSE EVENT 1 0.0000
166 COUGH 3 0.0000
167 PAIN IN EXTREMITY 3 0.0000
168 FALL 3 0.0000
169 DEPRESSION 2 0.0000
170 DIZZINESS 4 0.0000
171 NEUTROPENIA 1 0.0000
172 MEMORY IMPAIRMENT 1 0.0000
173 PRODUCT DOSE OMISSION ISSUE 2 0.0000
174 BLOOD PRESSURE INCREASED 1 0.0000
175 TREMOR 1 0.0000
176 MYALGIA 1 0.0000
177 URINARY TRACT INFECTION 1 0.0000
178 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
179 DYSPNOEA 3 0.0000
180 OVERDOSE 1 0.0000
181 CONSTIPATION 1 0.0000
182 WEIGHT INCREASED 1 0.0000
183 INCORRECT DOSE ADMINISTERED 1 0.0000